Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
In addition to the formal letter submitted to the U.S. Preventive Services Task Force (USPSTF), and noted on this web site on Friday, the Prostate Cancer Roundtable has, this morning, also issued a media release, signed by the same 10 members of the Roundtable.
Filed under: Diagnosis, Risk | Tagged: recommendation, Roundtable, USPSTF | 5 Comments »
Larry Axmaker is an 8-year prostate cancer survivor and very happy he had regular PSA screenings!
Filed under: Diagnosis, Risk | Tagged: recommendation, screening, testing, USPSTF | 1 Comment »
According to new data presented at the Frontiers in Cancer Prevention Research meeting ongoing this week in Boston, MA, some 70 percent of prostate cancer patients participating in a survey in Michigan reported long-term, treatment-related, adverse effects after first-line treatment with surgery or radiation therapy.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse effects, follow-up, lontg-term, radiation, surgery | 6 Comments »
Ten members of the Prostate Cancer Roundtable have today submitted a joint letter to the U.S. Preventive Services Task Force commenting on the recent draft recommendation of a “D” grade for use of the PSA test in screening for prostate cancer among men who do not have symptoms that are highly suspicious for prostate cancer, [...]
Filed under: Diagnosis, Risk | Tagged: PSA testing, risk, screening, USPSTF | 1 Comment »
Data from a prospective, randomized, Phase II clinical trial have shown that men diagnosed with early stage prostate cancer can decrease their risk for prostate cancer cell proliferation through use of a low-fat diet and fish oil capsules.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: diet, fish oil, proliferation, risk | Leave a Comment »
This week’s issue issue of the New England Journal of Medicine includes four perspective articles on the recent draft recommendation about PSA screening issued by the U.S. Preventive Services Task Force (USPSTF).
Filed under: Diagnosis, Risk | Tagged: PSA, recommendation, screening, testing, USPSTF | 5 Comments »
A report on the CNBC web site today discusses an article published earlier this week in the Archives of Internal Medicine. The premise of this article is that for the majority of women diagnosed with breast cancer who claim that their life was saved by a mammogram, there is limited justification for this highly emotionally, [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | 10 Comments »
According to data from a prospective study of prostate cancer outcomes conducted by researchers at the Mayo Clinic, the PSA test is “valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer.”
Filed under: Diagnosis, Management, Risk | Tagged: benefit, biopsy, PSA, risk | 3 Comments »
According to an article published today in The Boston Globe, the Dana-Farber Cancer Center and Brigham and Women’s Hospital are working together to initiate development of a very large, cancer-specific, genetic and clinical database.
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Brigham and Women's, clinical, Dana-Farber, database, genetic, tumor | Leave a Comment »
A newly published paper in the Journal of Urology describes a multi-center, prospective study of the potential of the investigational, urine-based, ProCaM™ assay as a test to offer improved evaluation of the need for prostate biopsy among men with an initial total serum PSA level between 2 and 10 ng/ml.
Filed under: Diagnosis, Risk | Tagged: biopsy, Diagnosis, epigenetic, ProCaM, PSA, risk, test | 7 Comments »
According to another publication based on data from the Physicians’ Health Study, “Quality of life outcomes in men who underwent delayed treatment after initially waiting were not worse than in men who underwent immediate treatment.”
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: immediate treatment, outcome, Physicians' Health Study, quality of life, watchful waiting | 7 Comments »
It has been noted previously in this blog that we are improving our ability to accurately identify localized prostate cancer using several types of imaging technology.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Diagnosis, identificantion, monitoring, MRI | 26 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site